Infiltration and extravasation.

The Infusion Nurses Society's national standards of practice require that a nurse who administers IV medication or fluid know its adverse effects and appropriate interventions to take before starting the infusion. A serious complication is the inadvertent administration of a solution or medication into the tissue surrounding the IV catheter--when it is a nonvesicant solution or medication, it is called infiltration; when it is a vesicant medication, it is called extravasation. Both infiltration and extravasation can have serious consequences: the patient may need surgical intervention resulting in large scars, experience limitation of function, or even require amputation. Another long-term effect is complex regional pain syndrome, a neurologic syndrome that requires long-term pain management. These outcomes can be prevented by using appropriate nursing interventions during IV catheter insertion and early recognition and intervention upon the first signs and symptoms of infiltration and extravasation. Nursing interventions include early recognition, prevention, and treatment (including the controversial use of antidotes, and heat and cold therapy). Steps to manage infiltration and extravasation are presented.

[1]  K. So,et al.  The Use of Hyaluronidase for Treatment of Extravasations in a Premature Infant , 2007 .

[2]  A. Shamseddine,et al.  Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing. , 2004, The Lancet. Oncology.

[3]  J. Hankins... Infusion therapy in clinical practice , 2001 .

[4]  W. V. van Vloten,et al.  Localized bullous eruptions caused by extravasation of commonly used intravenous infusion fluids. , 1991, Dermatologica.

[5]  S. Phelps,et al.  Risk factors affecting infiltration of peripheral venous lines in infants. , 1987, The Journal of pediatrics.

[6]  S. Langer,et al.  DEXRAZOXANE - A PROMISING ANTIDOTE IN THE TREATMENT OF ACCIDENTAL EXTRAVASATION OF ANTHRACYCLINES , 2003, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

[7]  W. Akeson,et al.  Hyperbaric oxygen reduces edema and necrosis of skeletal muscle in compartment syndromes associated with hemorrhagic hypotension. , 1986, The Journal of bone and joint surgery. American volume.

[8]  W. Raszka,et al.  The use of hyaluronidase in the treatment of intravenous extravasation injuries. , 1990, Journal of perinatology : official journal of the California Perinatal Association.

[9]  F. A. Matsen,et al.  Fasciotomy in the treatment of the acute compartment syndrome. , 1976, The Journal of bone and joint surgery. American volume.

[10]  J. Truchot 8 – Regulation of Acid—Base Balance , 1983 .

[11]  D. Alberts,et al.  Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse. , 1985, Journal of the National Cancer Institute.

[12]  P. Cronier,et al.  Hyperbaric oxygen therapy in the management of crush injuries: a randomized double-blind placebo-controlled clinical trial. , 1996, The Journal of trauma.

[13]  G. Bertelli,et al.  Hyaluronidase as an antidote to extravasation ofVinca alkaloids: Clinical results , 2005, Journal of Cancer Research and Clinical Oncology.

[14]  Bass Jw,et al.  The use of hyaluronidase in the treatment of intravenous extravasation injuries. , 1990 .

[15]  R. Cohan,et al.  Extravasation of nonionic radiologic contrast media: efficacy of conservative treatment. , 1990, Radiology.

[16]  D Camp-Sorrell,et al.  Developing extravasation protocols and monitoring outcomes. , 1998, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[17]  G. Rayan,et al.  Intravenous catheter complications in the hand and forearm. , 2004, The Journal of trauma.

[18]  Y. Sako,et al.  Pedal gangrene associated with the use of dopamine. , 1975, The New England journal of medicine.

[19]  L. A. Montgomery,et al.  Guideline for i.v. infiltrations in pediatric patients. , 1999, Pediatric nursing.

[20]  A. Toklu,et al.  Hyperbaric Oxygen Therapy in Adriamycin Extravasation: An Experimental Animal Study , 2000, Annals of plastic surgery.

[21]  R. Giunta Early subcutaneous wash-out in acute extravasations. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  G. Schears Summary of Product Trials for 10, 164 Patients: Comparing an Intravenous Stabilizing Device to Tape , 2006, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[23]  B. L. Gahart,et al.  Intravenous Medications: A Handbook for Nurses and Allied Health Professionals , 1977 .

[24]  N. Szeverenyi,et al.  Effect of warm and cold applications on the resolution of i.v. infiltrations. , 1993, Research in nursing & health.

[25]  S. B. Moody,et al.  Treatment of Peripheral Ischemia Secondary to Lidocaine Containing Epinephrine , 1989, Annals of plastic surgery.

[26]  D. Larson Treatment of tissue extravasation by antitumor agents , 1982, Cancer.

[27]  Linda Duncan,et al.  Infusion Nursing: Aspects of Practice Liability , 2007, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

[28]  G. Zucker Use of phentolamine to prevent necrosis due to levarterenol. , 1957, Journal of the American Medical Association.

[29]  R. Dorr,et al.  Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  R. Dorr,et al.  Antidotes to vesicant chemotherapy extravasations. , 1990, Blood reviews.

[31]  G. Greene,et al.  Nafcillin extravasation injury. Use of hyaluronidase as an antidote. , 1981, American journal of diseases of children.

[32]  R. Wickham,et al.  Vesicant extravasation part II: Evidence-based management and continuing controversies. , 2006, Oncology nursing forum.

[33]  P. Willemse,et al.  A new conservative approach to extravasation of anthracyclines with dimethylsulfoxide and dexrazoxane. , 2001, Acta oncologica.

[34]  N. J. Bush Mitoxantrone-induced extravasation. , 2005 .

[35]  O. Garrone,et al.  Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  R. Kaplan,et al.  A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  N. Scuderi,et al.  Antitumor Agents: Extravasation, Management, and Surgical Treatment , 1994, Annals of plastic surgery.

[38]  G. Bertelli Prevention and Management of Extravasation of Cytotoxic Drugs , 1995, Drug safety.

[39]  E. Woltering,et al.  DMSO protects against adriamycin-induced tissue necrosis. , 1992, The Journal of surgical research.

[40]  D. Larson,et al.  Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  A. Hargens,et al.  Acute compartment syndromes. , 1983, The Surgical clinics of North America.

[42]  J. Mulliken,et al.  Major intravenous extravasation injuries. , 1979, American journal of surgery.

[43]  W. Akeson,et al.  Reduction of skeletal muscle necrosis using intermittent hyperbaric oxygen in a model compartment syndrome. , 1983, The Journal of bone and joint surgery. American volume.

[44]  D. Redelmeier,et al.  Adhesive tape and intravascular-catheter-associated infections , 1999, Journal of General Internal Medicine.

[45]  C. Akman,et al.  Intrathoracic Extravasation of Antineoplastic Agents: Case Report and Systematic Review , 2003, American journal of clinical oncology.

[46]  S. Langer Dexrazoxane for anthracycline extravasation , 2000, Expert review of anticancer therapy.

[47]  F. Lombardo,et al.  Extravasation of chemotherapeutic agents: prevention and treatment. , 2006, Seminars in oncology.

[48]  D. Schrijvers Extravasation: a dreaded complication of chemotherapy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[49]  Js Gregory Statlock catheter securement device significantly reduces central venous catheter complications , 2000 .

[50]  R. Wickham,et al.  Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. , 2006, Oncology nursing forum.

[51]  H. Langstein,et al.  Retrospective Study of the Management of Chemotherapeutic Extravasation Injury , 2002, Annals of plastic surgery.

[52]  T. Kuwahara,et al.  Experimental infusion phlebitis: tolerance pH of peripheral vein. , 1999, The Journal of toxicological sciences.

[53]  D. Louis,et al.  Complex regional pain syndrome type I in the upper extremity. , 2006, Clinics in occupational and environmental medicine.

[54]  C. Langlotz,et al.  Contrast media reactions and extravasation: relationship to intravenous injection rates. , 1998, Radiology.

[55]  N. Szeverenyi,et al.  Effect of elevation on intravenous extravasations. , 1994, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[56]  H. Thomsen,et al.  Contrast medium extravasation injury: guidelines for prevention and management , 2002, European Radiology.

[57]  J. Pettit,et al.  Intravenous extravasation: Mechanisms, management, and prevention , 1993 .

[58]  D. Alberts,et al.  Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse. , 1983, Cancer treatment reports.

[59]  M. Sehested,et al.  Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[60]  O. Bayer,et al.  Extravasation injury in the perioperative setting. , 2005, Anesthesia and analgesia.

[61]  M. Sehested,et al.  Treatment of anthracycline extravasation with dexrazoxane. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[62]  T. Milward,et al.  Severe extravasation injury: an avoidable iatrogenic disaster? , 1985, British medical journal.

[63]  S. Kahn,et al.  The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. , 2002, The American journal of medicine.

[64]  N. Gaze TISSUE NECROSIS CAUSED BY COMMONLY USED INTRAVENOUS INFUSIONS , 1978, The Lancet.

[65]  J. Disa,et al.  Prevention of Adriamycin‐Induced Full‐Thickness Skin Loss Using Hyaluronidase Infiltration , 1998, Plastic and reconstructive surgery.

[66]  M. Sehested,et al.  Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone , 2005, Cancer Chemotherapy and Pharmacology.

[67]  Derek W Liau Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis , 2006 .

[68]  M. Friedman,et al.  Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. , 1980, Cancer treatment reviews.

[69]  M. Styler,et al.  Extravasation of systemic hemato-oncological therapies. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  D. Wood A comparative study of two securement techniques for short peripheral intravenous catheters. , 1997, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[71]  C. Engelking,et al.  Vesicant extravasation: myths and realities. , 1995, Oncology nursing forum.

[72]  M. O’Sullivan,et al.  Outcome of compartment syndrome following intramedullary nailing of tibial diaphyseal fractures. , 2001, Injury.

[73]  T. Kuwahara,et al.  Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. , 1998, Nutrition.

[74]  F. Heckler Current thoughts on extravasation injuries. , 1989, Clinics in plastic surgery.

[75]  L. Schulmeister,et al.  Chemotherapy extravasation from implanted ports. , 2000, Oncology nursing forum.

[76]  G. Giaccone,et al.  Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[77]  P. Saip,et al.  Totally implantable venous-access ports: local problems and extravasation injury. , 2002, The Lancet. Oncology.

[78]  E Kassner,et al.  Evaluation and Treatment of Chemotherapy Extravasation Injuries , 2000, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[79]  G. Hamilton,et al.  Acute compartment syndromes , 2002, The British journal of surgery.

[80]  S F Viegas,et al.  Causes of upper extremity compartment syndrome. , 1998, Hand clinics.

[81]  H. Stoll,et al.  Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and α-tocopherole , 1987 .

[82]  R. Dorr,et al.  Cutaneous ulceration due to contrast extravasation. Experimental assessment of injury and potential antidotes. , 1991, Investigative radiology.

[83]  L. Hadaway,et al.  The diverse and conflicting standards and practices in infusion therapy. , 2002 .

[84]  R. Peterfreund,et al.  Compartment syndrome of the upper arm after pressurized infiltration of intravenous fluid. , 1997, Journal of clinical anesthesia.

[85]  K. O'Connor,et al.  A prospective study of two intravenous catheter securement techniques in a skilled nursing facility. , 1999, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society.

[86]  J. Chan,et al.  A pediatric protocol for management of extravasation injuries. , 1993, Pediatric nursing.

[87]  Krishna Shankara Narayanan,et al.  Hyperbaric Oxygen Therapy and Free Radical Production: An Experimental Study in Doxorubicin (Adriamycin) Extravasation Injuries , 1997, Annals of plastic surgery.

[88]  M. Ringer,et al.  Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. , 1991, Annals of internal medicine.